Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-12-10

Clinical Trial Update: Neuclare Device for Temporary Improvement of Executive Function in Patients With Mild Cognitive Impairment and Prodromal Alzheimer's Disease [NA]

View source ↗

Summary

Clinical trial update on the Neuclare Device to temporarily improve executive function in individuals with mild cognitive impairment and prodromal Alzheimer's d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neuclare Device

Snippet

Sponsor: Deepsonbio | Conditions: Mild Cognitive Impairment, Alzheimer's Disease(AD) | NA | Status: RECRUITING